Jam

BeWhere Holdings secured an order for 8,000 BeMini asset trackers with FirstNet connectivity, delivering by the end of 2025. Integrated into the FirstNet ecosystem, the BeMini is designed for tracking smaller assets for first responders and public safety organizations. These FirstNet-ready trackers provide real-time location and condition monitoring, enhancing situational awareness and incident response. AT&T highlighted BeMini will enable first responders to efficiently manage assets in the field.

Jack in the Box celebrates its 10th year partnering with No Kid Hungry, having raised over $6 million since 2015. This September, customers donating $1 to No Kid Hungry via in-store or the Jack app will receive a coupon for free curly fries. Each dollar donated provides approximately 10 meals to children. The initiative aims to fight childhood hunger while incentivizing customer participation, reinforcing loyalty, and driving traffic. No Kid Hungry supports programs ensuring access to nutritious meals for children in need

Abercrombie & Fitch (ANF) partners with the Dallas Cowboys and Cheerleaders as the Official Fashion Partner in a multi-year deal, marking Abercrombie’s first NFL team collaboration. Licensed Cowboys merchandise will be available at select pro-shops and AT&T Stadium. Cowboys players CeeDee Lamb and Jake Ferguson will participate in the “Style Concierge” program, with Lamb debuting his own apparel line this season. This partnership aims to blend fashion and football, extending beyond game day.

REGENXBIO (Nasdaq: RGNX) will participate in several investor conferences in September 2025, including events hosted by Wells Fargo, Morgan Stanley, Baird, and H.C. Wainwright. The company will engage in one-on-one meetings and fireside chats to discuss its strategic vision, clinical progress, and the potential of its AAV gene therapies for rare and retinal diseases, including RGX-202 for Duchenne muscular dystrophy and surabgene lomparvovec (ABBV-RGX-314) for wet AMD and diabetic retinopathy. Webcasts will be available on REGENXBIO’s website.

WuXi Biologics (2269.HK) announced SBTi approval of its near-term and net-zero GHG emissions reduction targets, aligning with 1.5°C pathways and committing to net-zero across its value chain by 2050. As a leading Green CRDMO, WuXi Biologics implements a comprehensive strategy, engaging suppliers to reduce its environmental footprint. CEO Dr. Chris Chen views this as a catalyst for further action and delivering ESG excellence. The company holds MSCI AAA Rating, EcoVadis Platinum Medal, and DJSI listing.

8×8, Inc. has extended its partnership with Southampton FC, continuing as an official partner for Men’s and Women’s First Teams through the 2025/26 season. 8×8’s cloud-based technology is integral to the club’s operations, enhancing matchday experiences and fan engagement through streamlined communications. The partnership focuses on fostering deeper connections with supporters via personalized interactions and timely updates. The renewed agreement includes increased brand visibility and collaborative community outreach programs, leveraging 8×8’s unified platform to elevate fan experiences and operational efficiency.

CMB.TECH (CMBT) reported mixed Q2 2025 results. While revenue increased to $387.8 million, the company posted a net loss of $7.6 million, a stark contrast to the $184.4 million profit in Q2 2024. EBITDA also declined to $224.1 million. The merger with Golden Ocean was completed, creating a 250-vessel fleet. CMB.TECH declared an interim dividend of $0.05 USD and maintains a strong contract backlog of $2.93 billion. Vessel sales generated significant capital gains. Legal challenges from Golden Ocean shareholders remain.

Cognition Therapeutics (CGTX) announced a $30 million direct offering of 14.7 million common shares to two new institutional investors. Closing is expected around August 29, 2025. Proceeds will fund Phase 3 program preparation for zervimesine in neurodegenerative disorders, working capital, and general corporate purposes. Titan Partners Group acted as the sole placement agent. This secures funding to advance zervimesine to Phase 3 trials, however, the offering causes share dilution.

SK hynix has begun shipping mobile DRAM featuring industry-first High-K EMC, significantly improving thermal management. This innovation boosts thermal conductivity by 3.5x and reduces thermal resistance by 47%, mitigating heat issues in on-device AI applications, where rising data transfer rates generate considerable heat. The breakthrough is achieved by incorporating Alumina into Silica-based EMC. SK hynix aims to lead in next-generation mobile DRAM through continued material innovation, enhancing performance and extending device lifespan.

General Enterprise Ventures (GEVI) announced a 1-for-6 reverse stock split, effective August 27, 2025, reducing outstanding shares to approximately 14.6 million. The stock will trade as GEVID temporarily before reverting to GEVI. This strategic move aims to meet national securities exchange listing requirements and attract institutional investors. The split won’t affect percentage ownership; fractional shares will be rounded up. The company, through its subsidiary Mighty Fire Breaker, seeks growth in wildfire prevention technology.